Robust Quarterly Result Lifted LeMaitre Vascular (LMAT) in Q2

Conestoga Capital Advisors' Q2 2024 investor letter discusses the market moderation, with small-cap stocks underperforming. They highlighted LeMaitre Vascular, Inc. as a notable stock pick, showing growth potential. They emphasize AI stocks for higher returns in a shorter timeframe.